Global Nuclear Medicine Market Size, Status and Forecast 2023

Report ID: 1234801 | Published Date: Oct 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tc-99
        1.2.3 I-123/131
        1.2.4 In-111
        1.2.5 Xe-133
        1.2.6 Th-201
        1.2.7 Ga-67
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Nuclear Medicine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostic
        1.3.3 Therapeutic
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Nuclear Medicine Market Perspective (2016-2027)
    2.2 Nuclear Medicine Growth Trends by Regions
        2.2.1 Nuclear Medicine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Nuclear Medicine Historic Market Share by Regions (2016-2021)
        2.2.3 Nuclear Medicine Forecasted Market Size by Regions (2022-2027)
    2.3 Nuclear Medicine Industry Dynamic
        2.3.1 Nuclear Medicine Market Trends
        2.3.2 Nuclear Medicine Market Drivers
        2.3.3 Nuclear Medicine Market Challenges
        2.3.4 Nuclear Medicine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Nuclear Medicine Players by Revenue
        3.1.1 Global Top Nuclear Medicine Players by Revenue (2016-2021)
        3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2016-2021)
    3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Nuclear Medicine Revenue
    3.4 Global Nuclear Medicine Market Concentration Ratio
        3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2020
    3.5 Nuclear Medicine Key Players Head office and Area Served
    3.6 Key Players Nuclear Medicine Product Solution and Service
    3.7 Date of Enter into Nuclear Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Nuclear Medicine Breakdown Data by Type
    4.1 Global Nuclear Medicine Historic Market Size by Type (2016-2021)
    4.2 Global Nuclear Medicine Forecasted Market Size by Type (2022-2027)

5 Nuclear Medicine Breakdown Data by Application
    5.1 Global Nuclear Medicine Historic Market Size by Application (2016-2021)
    5.2 Global Nuclear Medicine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Nuclear Medicine Market Size (2016-2027)
    6.2 North America Nuclear Medicine Market Size by Type
        6.2.1 North America Nuclear Medicine Market Size by Type (2016-2021)
        6.2.2 North America Nuclear Medicine Market Size by Type (2022-2027)
        6.2.3 North America Nuclear Medicine Market Size by Type (2016-2027)
    6.3 North America Nuclear Medicine Market Size by Application
        6.3.1 North America Nuclear Medicine Market Size by Application (2016-2021)
        6.3.2 North America Nuclear Medicine Market Size by Application (2022-2027)
        6.3.3 North America Nuclear Medicine Market Size by Application (2016-2027)
    6.4 North America Nuclear Medicine Market Size by Country
        6.4.1 North America Nuclear Medicine Market Size by Country (2016-2021)
        6.4.2 North America Nuclear Medicine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Nuclear Medicine Market Size (2016-2027)
    7.2 Europe Nuclear Medicine Market Size by Type
        7.2.1 Europe Nuclear Medicine Market Size by Type (2016-2021)
        7.2.2 Europe Nuclear Medicine Market Size by Type (2022-2027)
        7.2.3 Europe Nuclear Medicine Market Size by Type (2016-2027)
    7.3 Europe Nuclear Medicine Market Size by Application
        7.3.1 Europe Nuclear Medicine Market Size by Application (2016-2021)
        7.3.2 Europe Nuclear Medicine Market Size by Application (2022-2027)
        7.3.3 Europe Nuclear Medicine Market Size by Application (2016-2027)
    7.4 Europe Nuclear Medicine Market Size by Country
        7.4.1 Europe Nuclear Medicine Market Size by Country (2016-2021)
        7.4.2 Europe Nuclear Medicine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Nuclear Medicine Market Size (2016-2027)
    8.2 Asia-Pacific Nuclear Medicine Market Size by Type
        8.2.1 Asia-Pacific Nuclear Medicine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Nuclear Medicine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Nuclear Medicine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Nuclear Medicine Market Size by Application
        8.3.1 Asia-Pacific Nuclear Medicine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Nuclear Medicine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Nuclear Medicine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Nuclear Medicine Market Size by Region
        8.4.1 Asia-Pacific Nuclear Medicine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Nuclear Medicine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Nuclear Medicine Market Size (2016-2027)
    9.2 Latin America Nuclear Medicine Market Size by Type
        9.2.1 Latin America Nuclear Medicine Market Size by Type (2016-2021)
        9.2.2 Latin America Nuclear Medicine Market Size by Type (2022-2027)
        9.2.3 Latin America Nuclear Medicine Market Size by Type (2016-2027)
    9.3 Latin America Nuclear Medicine Market Size by Application
        9.3.1 Latin America Nuclear Medicine Market Size by Application (2016-2021)
        9.3.2 Latin America Nuclear Medicine Market Size by Application (2022-2027)
        9.3.3 Latin America Nuclear Medicine Market Size by Application (2016-2027)
    9.4 Latin America Nuclear Medicine Market Size by Country
        9.4.1 Latin America Nuclear Medicine Market Size by Country (2016-2021)
        9.4.2 Latin America Nuclear Medicine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Nuclear Medicine Market Size (2016-2027)
    10.2 Middle East & Africa Nuclear Medicine Market Size by Type
        10.2.1 Middle East & Africa Nuclear Medicine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Nuclear Medicine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Nuclear Medicine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Nuclear Medicine Market Size by Application
        10.3.1 Middle East & Africa Nuclear Medicine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Nuclear Medicine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Nuclear Medicine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Nuclear Medicine Market Size by Country
        10.4.1 Middle East & Africa Nuclear Medicine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Nuclear Medicine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Company Details
        11.1.2 GE Healthcare Business Overview
        11.1.3 GE Healthcare Nuclear Medicine Introduction
        11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2016-2021)
        11.1.5 GE Healthcare Recent Development
    11.2 Bracco Imaging
        11.2.1 Bracco Imaging Company Details
        11.2.2 Bracco Imaging Business Overview
        11.2.3 Bracco Imaging Nuclear Medicine Introduction
        11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2016-2021)
        11.2.5 Bracco Imaging Recent Development
    11.3 Mallinckrodt
        11.3.1 Mallinckrodt Company Details
        11.3.2 Mallinckrodt Business Overview
        11.3.3 Mallinckrodt Nuclear Medicine Introduction
        11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2016-2021)
        11.3.5 Mallinckrodt Recent Development
    11.4 Lantheus Medical Imaging
        11.4.1 Lantheus Medical Imaging Company Details
        11.4.2 Lantheus Medical Imaging Business Overview
        11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
        11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2016-2021)
        11.4.5 Lantheus Medical Imaging Recent Development
    11.5 Bayer
        11.5.1 Bayer Company Details
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Nuclear Medicine Introduction
        11.5.4 Bayer Revenue in Nuclear Medicine Business (2016-2021)
        11.5.5 Bayer Recent Development
    11.6 Triad Isotopes
        11.6.1 Triad Isotopes Company Details
        11.6.2 Triad Isotopes Business Overview
        11.6.3 Triad Isotopes Nuclear Medicine Introduction
        11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2016-2021)
        11.6.5 Triad Isotopes Recent Development
    11.7 Nordion
        11.7.1 Nordion Company Details
        11.7.2 Nordion Business Overview
        11.7.3 Nordion Nuclear Medicine Introduction
        11.7.4 Nordion Revenue in Nuclear Medicine Business (2016-2021)
        11.7.5 Nordion Recent Development
    11.8 Jubilant Pharma
        11.8.1 Jubilant Pharma Company Details
        11.8.2 Jubilant Pharma Business Overview
        11.8.3 Jubilant Pharma Nuclear Medicine Introduction
        11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2016-2021)
        11.8.5 Jubilant Pharma Recent Development
    11.9 Eli Lilly
        11.9.1 Eli Lilly Company Details
        11.9.2 Eli Lilly Business Overview
        11.9.3 Eli Lilly Nuclear Medicine Introduction
        11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2016-2021)
        11.9.5 Eli Lilly Recent Development
    11.10 SIEMENS
        11.10.1 SIEMENS Company Details
        11.10.2 SIEMENS Business Overview
        11.10.3 SIEMENS Nuclear Medicine Introduction
        11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2016-2021)
        11.10.5 SIEMENS Recent Development
    11.11 China Isotope & Radiation
        11.11.1 China Isotope & Radiation Company Details
        11.11.2 China Isotope & Radiation Business Overview
        11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
        11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2016-2021)
        11.11.5 China Isotope & Radiation Recent Development
    11.12 Dongcheng
        11.12.1 Dongcheng Company Details
        11.12.2 Dongcheng Business Overview
        11.12.3 Dongcheng Nuclear Medicine Introduction
        11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2016-2021)
        11.12.5 Dongcheng Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tc-99
    Table 3. Key Players of I-123/131
    Table 4. Key Players of In-111
    Table 5. Key Players of Xe-133
    Table 6. Key Players of Th-201
    Table 7. Key Players of Ga-67
    Table 8. Key Players of Others
    Table 9. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Nuclear Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Nuclear Medicine Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Nuclear Medicine Market Share by Regions (2016-2021)
    Table 13. Global Nuclear Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Nuclear Medicine Market Share by Regions (2022-2027)
    Table 15. Nuclear Medicine Market Trends
    Table 16. Nuclear Medicine Market Drivers
    Table 17. Nuclear Medicine Market Challenges
    Table 18. Nuclear Medicine Market Restraints
    Table 19. Global Nuclear Medicine Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Nuclear Medicine Market Share by Players (2016-2021)
    Table 21. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine as of 2020)
    Table 22. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Nuclear Medicine Product Solution and Service
    Table 26. Date of Enter into Nuclear Medicine Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Nuclear Medicine Revenue Market Share by Type (2016-2021)
    Table 30. Global Nuclear Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Nuclear Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Nuclear Medicine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Nuclear Medicine Revenue Market Share by Application (2016-2021)
    Table 34. Global Nuclear Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Nuclear Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Nuclear Medicine Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Nuclear Medicine Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Nuclear Medicine Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Nuclear Medicine Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Nuclear Medicine Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Nuclear Medicine Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Nuclear Medicine Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Nuclear Medicine Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. GE Healthcare Company Details
    Table 67. GE Healthcare Business Overview
    Table 68. GE Healthcare Nuclear Medicine Product
    Table 69. GE Healthcare Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 70. GE Healthcare Recent Development
    Table 71. Bracco Imaging Company Details
    Table 72. Bracco Imaging Business Overview
    Table 73. Bracco Imaging Nuclear Medicine Product
    Table 74. Bracco Imaging Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 75. Bracco Imaging Recent Development
    Table 76. Mallinckrodt Company Details
    Table 77. Mallinckrodt Business Overview
    Table 78. Mallinckrodt Nuclear Medicine Product
    Table 79. Mallinckrodt Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 80. Mallinckrodt Recent Development
    Table 81. Lantheus Medical Imaging Company Details
    Table 82. Lantheus Medical Imaging Business Overview
    Table 83. Lantheus Medical Imaging Nuclear Medicine Product
    Table 84. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 85. Lantheus Medical Imaging Recent Development
    Table 86. Bayer Company Details
    Table 87. Bayer Business Overview
    Table 88. Bayer Nuclear Medicine Product
    Table 89. Bayer Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 90. Bayer Recent Development
    Table 91. Triad Isotopes Company Details
    Table 92. Triad Isotopes Business Overview
    Table 93. Triad Isotopes Nuclear Medicine Product
    Table 94. Triad Isotopes Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 95. Triad Isotopes Recent Development
    Table 96. Nordion Company Details
    Table 97. Nordion Business Overview
    Table 98. Nordion Nuclear Medicine Product
    Table 99. Nordion Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 100. Nordion Recent Development
    Table 101. Jubilant Pharma Company Details
    Table 102. Jubilant Pharma Business Overview
    Table 103. Jubilant Pharma Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 104. Jubilant Pharma Recent Development
    Table 105. Eli Lilly Company Details
    Table 106. Eli Lilly Business Overview
    Table 107. Eli Lilly Nuclear Medicine Product
    Table 108. Eli Lilly Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 109. Eli Lilly Recent Development
    Table 110. SIEMENS Company Details
    Table 111. SIEMENS Business Overview
    Table 112. SIEMENS Nuclear Medicine Product
    Table 113. SIEMENS Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 114. SIEMENS Recent Development
    Table 115. China Isotope & Radiation Company Details
    Table 116. China Isotope & Radiation Business Overview
    Table 117. China Isotope & Radiation Nuclear Medicine Product
    Table 118. China Isotope & Radiation Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 119. China Isotope & Radiation Recent Development
    Table 120. Dongcheng Company Details
    Table 121. Dongcheng Business Overview
    Table 122. Dongcheng Nuclear Medicine Product
    Table 123. Dongcheng Revenue in Nuclear Medicine Business (2016-2021) & (US$ Million)
    Table 124. Dongcheng Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nuclear Medicine Market Share by Type: 2020 VS 2027
    Figure 2. Tc-99 Features
    Figure 3. I-123/131 Features
    Figure 4. In-111 Features
    Figure 5. Xe-133 Features
    Figure 6. Th-201 Features
    Figure 7. Ga-67 Features
    Figure 8. Others Features
    Figure 9. Global Nuclear Medicine Market Share by Application: 2020 VS 2027
    Figure 10. Diagnostic Case Studies
    Figure 11. Therapeutic Case Studies
    Figure 12. Nuclear Medicine Report Years Considered
    Figure 13. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Nuclear Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Nuclear Medicine Market Share by Regions: 2020 VS 2027
    Figure 16. Global Nuclear Medicine Market Share by Regions (2022-2027)
    Figure 17. Global Nuclear Medicine Market Share by Players in 2020
    Figure 18. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2020
    Figure 20. Global Nuclear Medicine Revenue Market Share by Type (2016-2021)
    Figure 21. Global Nuclear Medicine Revenue Market Share by Type (2022-2027)
    Figure 22. North America Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Nuclear Medicine Market Share by Type (2016-2027)
    Figure 24. North America Nuclear Medicine Market Share by Application (2016-2027)
    Figure 25. North America Nuclear Medicine Market Share by Country (2016-2027)
    Figure 26. United States Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Nuclear Medicine Market Share by Type (2016-2027)
    Figure 30. Europe Nuclear Medicine Market Share by Application (2016-2027)
    Figure 31. Europe Nuclear Medicine Market Share by Country (2016-2027)
    Figure 32. Germany Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Nuclear Medicine Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Nuclear Medicine Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Nuclear Medicine Market Share by Region (2016-2027)
    Figure 42. China Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Nuclear Medicine Market Share by Type (2016-2027)
    Figure 50. Latin America Nuclear Medicine Market Share by Application (2016-2027)
    Figure 51. Latin America Nuclear Medicine Market Share by Country (2016-2027)
    Figure 52. Mexico Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Nuclear Medicine Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Nuclear Medicine Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Nuclear Medicine Market Share by Country (2016-2027)
    Figure 58. Turkey Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Nuclear Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 62. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 63. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 64. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 65. Bayer Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 66. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 67. Nordion Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 68. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 69. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 70. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 71. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 72. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Frequently Asked Questions
Nuclear Medicine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nuclear Medicine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nuclear Medicine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cloud GIS

Cloud GIS market is segmented by company, region (country), by Type, and by Application. Players, ... Read More

ENT Surgical Devices

ENT Surgical Devices market is segmented by company, region (country), by Type, and by Applicatio ... Read More